Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 208216
Company: ACTAVIS LLC
Company: ACTAVIS LLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/29/2016 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208216s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/208216Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208216Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
06/08/2023 | SUPPL-6 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208216s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208216Orig1s006ltr.pdf | |
07/13/2020 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208216s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208216Orig1s005ltr.pdf | |
10/22/2018 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208216s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208216Orig1s002ltr.pdf | |
01/10/2018 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208216s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208216Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/08/2023 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208216s006lbl.pdf | |
07/13/2020 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208216s005lbl.pdf | |
10/22/2018 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208216s002lbl.pdf | |
01/10/2018 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208216s001lbl.pdf | |
04/29/2016 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208216s000lbl.pdf |
AZACITIDINE
POWDER;INTRAVENOUS, SUBCUTANEOUS; 100MG/VIAL
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 207475 | ACCORD HLTHCARE |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 208216 | ACTAVIS LLC |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 211549 | AMNEAL |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 209540 | CIPLA |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 201537 | DR REDDYS |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 215066 | EUGIA PHARMA |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 209337 | EUROHLTH INTL SARL |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 215905 | JIANGSU HANSOH PHARM |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 212128 | MEITHEAL |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 212580 | MSN LABS PVT LTD |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 207234 | NATCO PHARMA LTD |
AZACITIDINE | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 207518 | SHILPA MEDICARE |
VIDAZA | AZACITIDINE | 100MG/VIAL | POWDER;INTRAVENOUS, SUBCUTANEOUS | Prescription | Yes | AP | 050794 | BRISTOL-MYERS |